---
title: "ClearOne (CLRO) Soars 123% in Trading on Neurotech Merger Talks"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291967268.md"
description: "ClearOne (CLRO) surges 123% during regular trading on merger talks with a neurotech giant, volume hits 70.37M shares."
datetime: "2026-07-07T18:42:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291967268.md)
  - [en](https://longbridge.com/en/news/291967268.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291967268.md)
---

# ClearOne (CLRO) Soars 123% in Trading on Neurotech Merger Talks

ClearOne(CLRO.US) 盘中急涨**123.21%**，现报**15.625 美元**。

根据近期新闻，ClearOne 据悉正与一家神经技术巨头洽谈合并。该股早盘已飙升近 60% 至 11.17 美元，午后买盘持续涌入，推动涨幅进一步扩大至逾 123%，成交量达 7037.49 万股。

### Related Stocks

- [CLRO.US](https://longbridge.com/en/quote/CLRO.US.md)

## Related News & Research

- [ClearOne files draft information statement for Cortigent merger share issuance](https://longbridge.com/en/news/293076104.md)
- [ClearOne Disclosed Failure to Satisfy a Continued Listing Rule or Standard](https://longbridge.com/en/news/282586606.md)
- [ClearOne enters loan agreement with First Finance for up to $1 million at 11% interest](https://longbridge.com/en/news/291458334.md)
- [ClearOne enters merger deal to acquire Vivani unit Cortigent](https://longbridge.com/en/news/291841889.md)
- [Vivani Medical: Buy Rating Reaffirmed as Novo Nordisk Evaluation and Cortigent–ClearOne Merger Support $3.50 Price Target](https://longbridge.com/en/news/292224424.md)